AAAAAA
Results:
1-11
|
Results: 11
Authors:
Blanchette, V
Citation: V. Blanchette, Prophylaxis for haemophilia: state of the art, HAEMOPHILIA, 6, 2000, pp. 18-18
Authors:
Barnard, D
Blanchette, V
David, M
Feeny, D
McCusker, P
Wu, J
Woloski, M
Citation: D. Barnard et al., The burden of childhood ITP, INT J PED H, 7(1), 2000, pp. 13-15
Authors:
Patterson, BJ
Freedman, J
Blanchette, V
Sher, G
Pinkerton, P
Hannach, B
Meharchand, J
Lau, W
Boyce, N
Pinchefsky, E
Tasev, T
Pinchefsky, J
Poon, S
Shulman, L
Mack, P
Thomas, K
Blanchette, N
Greenspan, D
Panzarella, T
Citation: Bj. Patterson et al., Effect of premedication guidelines and leukoreduction on the rate of febrile nonhaemolytic platelet transfusion reactions, TRANSFUS M, 10(3), 2000, pp. 199-206
Authors:
Fouladi, M
Herman, R
Rolland-Grinton, M
Jones-Wallace, D
Blanchette, V
Calderwood, S
Doyle, J
Halperin, D
Leaker, M
Saunders, EF
Zipursky, A
Freedman, MH
Citation: M. Fouladi et al., Improved survival in severe acquired aplastic anemia of childhood, BONE MAR TR, 26(11), 2000, pp. 1149-1156
Authors:
Blanchette, V
Carcao, M
Citation: V. Blanchette et M. Carcao, Approach to the investigation and management of immune thrombocytopenic purpura in children, SEM HEMATOL, 37(3), 2000, pp. 299-314
Authors:
Lazarus, AH
Ellis, J
Blanchette, V
Freedman, J
Sheng-Tanner, X
Citation: Ah. Lazarus et al., Permeabilization and fixation conditions for intracellular flow cytometricdetection of the T-cell receptor zeta chain and other intracellular proteins in lymphocyte subpopulations (vol 32, pg 206, 1998), CYTOMETRY, 35(1), 1999, pp. 95-95
Authors:
Lazarus, AH
Crow, AR
Freedman, J
Blanchette, V
Hannach, B
Citation: Ah. Lazarus et al., Inhibition of a secondary human alloimmune response via the soluble activecomponent of CD154 (CD40L) in severe combined immune-deficient mice engrafted with human lymphocytes, TRANSFUSION, 39(8), 1999, pp. 818-823
Authors:
Wright, JF
Wang, H
Hornstein, A
Hogarth, M
Mody, M
Garvey, MB
Blanchette, V
Rock, G
Freedman, J
Citation: Jf. Wright et al., Characterization of platelet glycoproteins and platelet/endothelial cell antibodies in patients with thrombotic thrombocytopenic purpura, BR J HAEM, 107(3), 1999, pp. 546-555
Authors:
Crow, AR
Freedman, J
Hannach, B
Blanchette, V
Lazarus, AH
Citation: Ar. Crow et al., Antibody-mediated inhibition of the human alloimmune response to platelet transfusion in Hu-PBL-SCID mice, BR J HAEM, 104(4), 1999, pp. 919-924
Authors:
Blanchette, V
Carcao, M
Citation: V. Blanchette et M. Carcao, Intravenous immunoglobulin G and anti-D as therapeutic interventions in immune thrombocytopenic purpura, TRANSFUS SC, 19(3), 1998, pp. 279-288
Authors:
Chia, WK
Blanchette, V
Mody, M
Wright, JF
Freedman, J
Citation: Wk. Chia et al., Characterization of HIV-1-specific antibodies and HIV-1-crossreactive antibodies to platelets in HIV-1-infected haemophiliac patients, BR J HAEM, 103(4), 1998, pp. 1014-1022
Risultati:
1-11
|